Pharsight

Ventolin Hfa patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7832351 GLAXOSMITHKLINE Actuation indicator for a dispensing device
Jun, 2023

(9 months ago)

US7832351

(Pediatric)

GLAXOSMITHKLINE Actuation indicator for a dispensing device
Dec, 2023

(3 months ago)

US7500444 GLAXOSMITHKLINE Actuation indicator for a dispensing device
Feb, 2026

(1 year, 10 months from now)

US7500444

(Pediatric)

GLAXOSMITHKLINE Actuation indicator for a dispensing device
Aug, 2026

(2 years from now)

Ventolin Hfa is owned by Glaxosmithkline.

Ventolin Hfa contains Albuterol Sulfate.

Ventolin Hfa has a total of 4 drug patents out of which 2 drug patents have expired.

Expired drug patents of Ventolin Hfa are:

  • US7832351
  • US7832351*PED

Ventolin Hfa was authorised for market use on 19 April, 2001.

Ventolin Hfa is available in aerosol, metered;inhalation dosage forms.

The generics of Ventolin Hfa are possible to be released after 26 August, 2026.

Drugs and Companies using ALBUTEROL SULFATE ingredient

Market Authorisation Date: 19 April, 2001

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage

VENTOLIN HFA family patents

Family Patents